My current taxable portfolio is worth $48,081. I have $3,400 in an options account and $44,600 in my stock account.
At the end of June, I'll transfer anything above $50,000 to a savings account. If my account falls to $40,000, my husband will do an intervention and take the account away:)
I prematurely transferred $10,000 in May profits before the week closed out and then my $NBIX short rallied and left me 2k below my mark. So I am starting June with a small deficit. It was a really good learning lesson about locking in profits and controlling greed. All in all though, I'm very happy with May beyond the gray hairs I grew watching the market correct. I was reminded to wait for my target, execute it, and get out when it's time.
My goal is to earn between $1,000-2,000 weekly trading until I go on maternity leave in mid-October. It's ambitious, I know, especially for a part time trader. Sometimes I make it and other times I don't. I am giving myself until October to see if I can be successful with my goals. My family is expanding and my trading profits are going into a house downpayment savings account.
I am holding (and sometimes trading) ALXA, VVUS, BIOD, ARNA, JAZZ in my IRA or taxable in anticipation of October FDA approval dates. This month PGNX, QCOR and VVUS are on my play list. Each has a catalyst. The first two have FDA approval dates, June 4th and 11th respectively, the third is releasing clinical trial info for their erectile drug and has an FDA panel meeting for it's weight loss drug next month. I am also watching the American Society of Clinical Oncology (ASCO) annual meeting, which runs June 4th-8th in Chicago. Several bios are presenting clinical trial information and may be good for pop or drop plays. I am watching ARQL, KERX, AEZS, HNAB, GNBT, DCTH and CDLX.
For more info on ASCO plays, I'd suggest reading:
John Welsh's ASCO write up
Adam Feuerstein's ASCO write up on The Street
Biorunup's writeup ASCO and the "Run Up Method"
Mike Havrilla's ASCO Coverage (multiple links on his site)
Tuesday, June 1, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment